PDP seeks assurance from BJP on Article 370, AFSPA

December 27, 2014

Srinagar, Dec 27: The stalemate over government formation in Jammu and Kashmir continued for the fifth day today as PDP sought assurance from BJP over certain issues like safeguarding Article 370 and revocation of AFSPA which form the core agenda of the regional party.

Naeem Akhter"All options are still open, no decision has been taken yet on formation of government in the state with any other party," PDP spokesperson Naeem Akhter said.

He said the leadership of PDP, which emerged as the single largest party in the assembly elections, was discussing all its options for government formation including an alliance with the BJP.

"There are certain issues which form our core agenda and require an assurance that these will be accepted by our potential alliance partner, whichever party it might be," he said.

Akhter said his party's stand on safeguarding Article 370, which guarantees special status to Jammu and Kashmir within the Indian union, was non-negotiable.

He also said that the party was committed on revocation of Armed Forces Special Powers Act from the state, besides initiating a political process for resolution of Kashmir issue.

Asked if his party would consider the demand for rotational chief ministership from any future alliance partner, the PDP spokesman said the negotiations have not reached that stage with any of the parties.

He said Congress has also given a proposal for government formation to the PDP which is under the consideration by the party.

On the National Conference's offer of unconditional support to PDP for government formation, Akhter said his party has received no such communication so far from its arch rival.

"As and when such an offer is received we will surely discuss it and decide the future course of action," he said.

National Conference working president Omar Abdullah yesterday said his party had only conveyed a "verbal offer" to the PDP through an intermediary.

The PDP leadership is caught in a 'catch 22' situation with some influential leaders within the party strongly opposing an alliance with the BJP on the grounds that such a partnership can reverse the gains made by the party during recent times.

A senior PDP leader, on the condition of anonymity, said an alliance with the BJP which emerged as the second largest party with 25 seats, would be "suicidal" for the regional party.

"While good governance and development is a universal yearning among the people, people in a sensitive place like Kashmir also keenly watch the friends you keep. One of the reasons for decline of National Conference was its hob-nobbing with which ever party was in power at the centre," he said.

National Conference, which has 15 seats and can play a key role in government formation, withdrew from the race following open expression of dissent by some senior party leaders after reports suggested that the regional party had entered into parleys with BJP to cobble up an alliance.

The results for the state assembly elections on December 23 threw up a hung verdict with no party getting clear majority.

Congress, with 12 MLAs, is neither in a position to form the government or help PDP or National Conference to cross the 44 seat mark in the 87-member state assembly.

Congress spokesman Salman Nizami yesterday said the party was in touch with PDP and six other Independents to prevent BJP from coming to power in the state.

State Governor N N Vohra has invited PDP and BJP for separate discussions over government formation.

"The Governor has asked the two parties to inform him about the developments on government formation in the state," Raj Bhavan sources had said.

All eyes are now on the PDP to come up with its decision on government formation in the state.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 2,2020

New Delhi, Jun 2: India on Tuesday reported 8,171 more COVID-19 cases and 204 deaths in the last 24 hours as the country's virus count inches closer to two lakh, according to the Union Ministry of Health and Family Welfare.

The total number of cases in the country now stands at 1,98,706 including 97,581 active cases, 95,527 cured/discharged/migrated and 5,598 deaths.

Cases in Maharashtra have crossed 70,000 including over 30,000 recovered while Tamil Nadu's COVID-19 tally jumped to 23,495.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 27,2020

New Delhi, May 27: With 6,387 new coronavirus cases in the last 24 hours, India's count of COVID-19 rose to 1,51,767 on Wednesday, said the Union Ministry of Health and Family Welfare.

170 people have also died in the last 24 hours due to the infection.

Currently, there are 83,004 active cases while 64,425 COVID-19 positive patients have been cured/discharged and one has migrated. So far, a total of 4,337 deaths have taken place across the country.

Among all states, Maharashtra has the highest number of COVID-19 cases with 54,758. Tamil Nadu has 17,728 cases with Gujarat at 14,821 cases. The national capital has 14,465 reported cases of coronavirus.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.